| Abstract | Interferon therapy is the cornerstone of chronic hepatitis C treatment. Side effects of interferon include possible triggering or exacerbation of immune diseases in consequence of immunomodulatory effects. We describe the unique case, in which pyoderma gangrenosum and exacerbation of psoriasis were developed 8 weeks after pegylated interferon alpha 2a and ribavirin therapy in a 45-year-old woman. The therapy had to be stopped on account of pyoderma gangrenosum and exacerbation of psoriasis in spite of a biochemical response to the therapy for hepatitis C. The evolution was favorable after stopping treatment. Therefore, we propose this would suggest a possible autoimmune mechanism for the development of pyoderma gangrenosum and exacerbation of psoriasis with pegylated interferon therapy. A susceptible patient, who has an autoimmune disease before interferon therapy, had to be informed that interferons may induce de novo or exacerbate existing immune diseases by immunomodulatory actions. To the best of our knowledge, this is the first case report of pyoderma gangrenosum and psoriasis that resulted from pegylated interferon alpha 2a and ribavirin treatment of chronic hepatitis C. |
| Authors | Alper Yurci, Kadri Guven, Edip Torun, Sebnem Gursoy, Mevlut Baskol, Hulya Akgun, Omer Ozbakir, Mehmet Yucesoy
(Affiliation: Department of Gastroenterology, Erciyes University, School of Medicine, Kayseri, Turkey. yurci at erciyes.edu.tr)
|
| Journal | European journal of gastroenterology & hepatology
(Eur J Gastroenterol Hepatol)
Vol. 19
Issue 9
Pg. 811-5
(Sep 2007)
ISSN: 0954-691X England |
| PMID | 17700270
(Publication Type: Case Reports, Journal Article)
|
| Chemical References |
- Antiviral Agents
- Polyethylene Glycols
- peginterferon alfa-2a
- Ribavirin
- Interferon Alfa-2a
|
| Topics |
- Antiviral Agents
(adverse effects, therapeutic use)
- Drug Eruptions
(etiology, pathology)
- Drug Therapy, Combination
- Female
- Hepatitis C, Chronic
(drug therapy)
- Humans
- Interferon Alfa-2a
(adverse effects, therapeutic use)
- Middle Aged
- Polyethylene Glycols
(adverse effects, therapeutic use)
- Psoriasis
(chemically induced, pathology)
- Pyoderma Gangrenosum
(chemically induced, pathology)
- Ribavirin
(adverse effects, therapeutic use)
|
